Regulatory tracker: Takeda's subcutaneous Entyvio scores FDA approval in Crohn's disease
Welcome to 2024's regulatory tracker for Fierce Pharma. On this page, we're recording the regulatory progress of in-market products, including expansions into key geographies and new indications. Some of these updates may not make the bar for …